• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Digital Health Funding Hits $7.4B in Q1 2026 Driven by AI Drug Discovery and M&A

by Fred Pennic 04/20/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Digital Health Funding Hits $7.4B in Q1 2026 Driven by AI Drug Discovery and M&A

What You Should Know

  • The Spending Boom: Healthcare now captures nearly half of all vertical AI spend, projected to hit $1.5 billion in 2025 (more than tripling from $450 million the year prior), according to the latest CB Insights State of Digital Health Q1’26 report. 
  • The Readiness Gap: Despite the massive investment, early AI pilots routinely fail. Less than 20% of enterprise healthcare data is currently ready for AI without substantial preparation.
  • The Legacy Problem: Most healthcare data systems (like EHRs and CRMs) were built for billing, compliance, or sales tracking—not predictive modeling. This results in inconsistent data, such as mixed temperature units or non-standardized free-text diagnosis codes.

The Rise of the “Mega-Round”

Digital Health Funding Hits $7.4B in Q1 2026 Driven by AI Drug Discovery and M&A

Funding in Q1’26 rose to $7.4B, a sharp increase from the $5.9B seen in the previous quarter. This growth was largely concentrated in 19 mega-rounds ($100M+), which accounted for 60% of all capital raised.

  • Late-Stage Dominance: The median late-stage deal size skyrocketed to $108M, more than double the $48M median from Q4’25.
  • Unicorn Rebound: Eight new unicorns were minted this quarter—the highest single-quarter count in nearly four years.
  • Market Leaders: Category leaders like Devoted Health and Alan are now operating with $100M+ war chests, allowing them to remain private while expanding their distribution and acquisition capabilities.

M&A Strategy: Adoption Over Approval

Digital Health Funding Hits $7.4B in Q1 2026 Driven by AI Drug Discovery and M&A

M&A activity jumped 47% this quarter, with 56 deals closed. The market is now strictly prioritizing commercial adoption over simple regulatory clearance.

  • Abbott’s $23B Bet: In the quarter’s largest deal, Abbott acquired Exact Sciences to take its proven Cologuard screening model global.
  • The Adoption Premium: DeepHealth’s $269M acquisition of Gleamer was driven by a footprint of 700+ hospital contracts. Conversely, Oxipit—despite having a world-first autonomous AI certification—saw limited value due to negligible 2024 revenue ($27.6K).

Prior Authorization: The 2027 Forcing Function

With the CMS-0057-F deadline mandating electronic prior authorization by January 2027, investment is flooding into the space.

  • Pure-Play vs. Platform: Latent secured an $80M Series A as a specialized provider, while Adonis raised a $40M Series C to expand its broader revenue cycle platform.
  • Strategic Partnerships: Abridge and Availity collaborated to embed these capabilities directly into clinical workflows, while Samsung and b.well are integrating portable health records into Galaxy devices to meet CMS standards.

AI Drug Discovery: Speed Meets Novelty

Pharma is committing billions to AI to compress research timelines.

  • Timeline Compression: Earendil Labs raised $787M—the largest deal of the quarter—to support a deep learning platform that has already generated 40+ therapeutic programs. Takeda also committed up to $1.7B to Iambic Therapeutics, which moved a candidate to IND in just 24 months (vs. the 6-year industry average).
  • Novel Modalities: Early-stage capital is targeting platforms for new drug classes, such as Proxima ($80M for molecular glues) and Vibrant Therapeutics ($61M for macromolecular therapeutics).

The Battle for Healthcare AI Talent

Headcount is growing rapidly as the market shifts from development to enterprise deployment.

  • Headcount Surges: Tennr and Hippocratic AI are leading hiring in the model developer market, with Hippocratic expanding into pharma R&D following its acquisition of Grove.
  • Big Tech Competition: Anthropic grew its headcount by over 200% in the last year, launching a dedicated healthcare offering in Q1’26 to rival OpenAI.
  • Infrastructure Layer: Nvidia is positioning itself as the underlying compute layer for the industry, recording 6 new digital health business relationships this quarter.

For more information about the CBInsights Digital Health report, visit https://www.cbinsights.com/research/report/digital-health-trends-q1-2026/

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |